CMR Surgical, a Cambridge UK-based surgical robotic company, raised $600M in Series D funding.
The round was led by SoftBank Vision Fund 2 with participation from Ally Bridge Group, new investors RPMI Railpen, Tencent and Chimera, and existing investors LGT and its affiliate impact investing platform Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare.
Led by Per Vegard Nerseth, Chief Executive Officer, CMR works with surgeons and hospitals to provide a tool to make robotic keyhole surgery universally accessible. Versius is a surgical robotic system already launched in multiple geographies worldwide including across Europe, Australia, India and the Middle East.
The company intends to use the funds for the global commercialization of Versius and further develop its digital ecosystem, including new technological developments such as Versius Connect, an app for surgeons using the Versius surgical robotic system.
FinSMEs
29/06/2021